Checkpoint Inhibitor Immunotherapy during Pregnancy for Relapsed/Refractory Hodgkin Lymphoma. Evens AM, Brandt JS, Peer CJ, Yin T, et al. Am J Hematol 2022 Mar 14. doi: 10.1002/ajh.26527.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Evens AM, Brandt JS, Peer CJ, Yin T, et al. Checkpoint Inhibitor Immunotherapy during Pregnancy for Relapsed/Refractory Hodgkin Lymphoma. Am J Hematol 2022 Mar 14. doi: 10.1002/ajh.26527.
PMID: 35285979